Molnupiravir approved by FDA

In a new breakthrough, the Food and Drug Administration has authorized the emergency use of a new COVID-19 antiviral drug, Molnupiravir. A second anti-viral treatment is manufactured by pharmaceutical giant Merck and Ridgeback Biotherapeutics. The drug, Molnupiravir, works by disrupting the way the virus copies the genetic materials. The FDA insists the medication should only … Read more